WeiQing Venus So

2PUBLICATIONS
3CO-AUTHORS
Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Mar 03, 2025
Machine learning identifies clinical tumor mutation landscape pathways of resistance to checkpoint inhibitor therapy in NSCLC.

Vitalay Fomin, WeiQing Venus So, Richard Alex Barbieri

|Feb 23, 2023
Predictive biomarkers for PD-1/PD-L1 checkpoint inhibitor response in NSCLC: an analysis of clinical trial and real-world data.

WeiQing Venus So, David Dejardin, Eva Rossmann

Pageof 1